aPTT reagent sensitivity to progressive single FVIII deficiency or pan-deficiency of all factors
| FVIII activity, % . | aPTT, s* . | All factor activity, % . | aPTT, s* . |
|---|---|---|---|
| 100 | 28.6 | 100 | 29.4 |
| 90 | 28.6 | 90 | 30.1 |
| 80 | 29.6 | 80 | 31.9 |
| 70 | 30.7 | 70 | 33.9** |
| 60 | 31.5 | 60 | 37.4** |
| 50 | 32.5 | 50 | 43.0 |
| 40 | 34.3** | 40 | 51.9 |
| 30 | 36.1** | 30 | 69.9 |
| 20 | 39.1 | 20 | 108.0 |
| 15 | 40.5 | 15 | No clot |
| 10 | 44.5 | 10 | No clot |
| 5 | 49.6 | 5 | No clot |
| 1 | 61.1 | 1 | No clot |
| 0.001 | 79.6 | 0.001 | No clot |
| FVIII activity, % . | aPTT, s* . | All factor activity, % . | aPTT, s* . |
|---|---|---|---|
| 100 | 28.6 | 100 | 29.4 |
| 90 | 28.6 | 90 | 30.1 |
| 80 | 29.6 | 80 | 31.9 |
| 70 | 30.7 | 70 | 33.9** |
| 60 | 31.5 | 60 | 37.4** |
| 50 | 32.5 | 50 | 43.0 |
| 40 | 34.3** | 40 | 51.9 |
| 30 | 36.1** | 30 | 69.9 |
| 20 | 39.1 | 20 | 108.0 |
| 15 | 40.5 | 15 | No clot |
| 10 | 44.5 | 10 | No clot |
| 5 | 49.6 | 5 | No clot |
| 1 | 61.1 | 1 | No clot |
| 0.001 | 79.6 | 0.001 | No clot |